A Novel Ferroptosis-related LncRNA Signature for Prognosis Prediction in Gastric Cancer

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2021 Nov 14

PMID 34774009

Citations 26

Authors

Jianming Wei

Ye Zeng

Xibo Gao

Tong Liu

Affiliations

Soon will be listed here.

Abstract

Background: Gastric cancer (GC) is a common malignant cancer with a poor prognosis. Ferroptosis has been shown to play crucial roles in GC development. Long non-coding RNAs (lncRNAs) is also associated with tumor progression in GC. This study aimed to screen the prognostic ferroptosis-related lncRNAs and to construct a prognostic risk model for GC.

Methods: Ferroptosis-related lncRNAs from The Cancer Genome Atlas (TCGA) GC expression data was downloaded. First, single factor Cox proportional hazard regression analysis was used to select seven prognostic ferroptosis-related lncRNAs from TCGA database. And then, the selected lncRNAs were further included in the multivariate Cox proportional hazard regression analysis to establish the prognostic model. A nomogram was constructed to predict individual survival probability. Finally, we performed quantitative reverse transcription polymerase chain reaction (qRT-PCR) to verify the risk model.

Results: We constructed a prognostic ferroptosis-related lncRNA signature in this study. Kaplan-Meier curve analysis revealed a significantly better prognosis for the low-risk group than for the high-risk group (P = 2.036e-05). Multivariate Cox proportional risk regression analysis demonstrated that risk score was an independent prognostic factor [hazard ratio (HR) = 1.798, 95% confidence interval (CI) =1.410-2.291, P < 0.001]. A nomogram, receiver operating characteristic curve, and principal component analysis were used to predict individual prognosis. Finally, the expression levels of AP003392.1, AC245041.2, AP001271.1, and BOLA3-AS1 in GC cell lines and normal cell lines were tested by qRT-PCR.

Conclusions: This risk model was shown to be a novel method for predicting prognosis for GC patients.

Citing Articles

BDNF is a prognostic biomarker involved in the immune infiltration of lung adenocarcinoma and associated with programmed cell death.

Xia J, Zhuo W, Deng L, Yin S, Tang S, Yi L Oncol Lett. 2025; 29(4):191.

PMID: 40041412 PMC: 11877015. DOI: 10.3892/ol.2025.14937.

Development and experimental validation of a senescence-related long non-coding RNA signature for prognostic prediction and immune microenvironment characterization in gastric cancer patients.

Shi J, Hou Z, Fan L, Hu C, Ma N, Huang E J Gastrointest Oncol. 2025; 15(6):2413-2436.

PMID: 39816024 PMC: 11732332. DOI: 10.21037/jgo-24-792.

Construction of a prognostic model for gastric cancer based on immune infiltration and microenvironment, and exploration of MEF2C gene function.

Wang S, Wang Y, Guan L, Shen A, Huang R, Yuan S BMC Med Genomics. 2025; 18(1):13.

PMID: 39810215 PMC: 11734330. DOI: 10.1186/s12920-024-02082-4.

Identification and Verification of a Novel Disulfidptosis-Related lncRNAs Prognostic Signature to Predict the Prognosis and Immune Activity of Head and Neck Squamous Carcinoma.

Yin Z, Wang J, Zhu C, Xu C, Fang J, Li Q Iran J Public Health. 2024; 53(10):2328-2340.

PMID: 39544861 PMC: 11557754. DOI: 10.18502/ijph.v53i10.16720.

Ning B, Huang T, Liu Y, Wei Y Heliyon. 2024; 10(15):e34399.

PMID: 39144985 PMC: 11320146. DOI: 10.1016/j.heliyon.2024.e34399.

References

Schmitz S, Grote P, Herrmann B . Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016; 73(13):2491-509. PMC: 4894931. DOI: 10.1007/s00018-016-2174-5. View

Szikszai K, Krejcik Z, Klema J, Loudova N, Hrustincova A, Belickova M . LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome. Cancers (Basel). 2020; 12(10). PMC: 7598221. DOI: 10.3390/cancers12102726. View

Eusebi L, Telese A, Marasco G, Bazzoli F, Zagari R . Gastric cancer prevention strategies: A global perspective. J Gastroenterol Hepatol. 2020; 35(9):1495-1502. DOI: 10.1111/jgh.15037. View

Qi W, Li Z, Xia L, Dai J, Zhang Q, Wu C . LncRNA GABPB1-AS1 and GABPB1 regulate oxidative stress during erastin-induced ferroptosis in HepG2 hepatocellular carcinoma cells. Sci Rep. 2019; 9(1):16185. PMC: 6838315. DOI: 10.1038/s41598-019-52837-8. View

Wang Z, Chen X, Liu N, Shi Y, Liu Y, Ouyang L . A Nuclear Long Non-Coding RNA LINC00618 Accelerates Ferroptosis in a Manner Dependent upon Apoptosis. Mol Ther. 2020; 29(1):263-274. PMC: 7791008. DOI: 10.1016/j.ymthe.2020.09.024. View

Wei J, Wang J, Gao X, Qi F . Identification of differentially expressed circRNAs and a novel hsa_circ_0000144 that promote tumor growth in gastric cancer. Cancer Cell Int. 2019; 19:268. PMC: 6794874. DOI: 10.1186/s12935-019-0975-y. View

Lai Y, Zhang Z, Li J, Li W, Huang Z, Zhang C . STYK1/NOK correlates with ferroptosis in non-small cell lung carcinoma. Biochem Biophys Res Commun. 2019; 519(4):659-666. DOI: 10.1016/j.bbrc.2019.09.032. View

Liao Y, Xiao H, Cheng M, Fan X . Bioinformatics Analysis Reveals Biomarkers With Cancer Stem Cell Characteristics in Lung Squamous Cell Carcinoma. Front Genet. 2020; 11:427. PMC: 7247832. DOI: 10.3389/fgene.2020.00427. View

Zhou Z, Huang R, Chai R, Zhou X, Hu Z, Wang W . Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma. Aging (Albany NY). 2018; 10(11):3185-3209. PMC: 6286858. DOI: 10.18632/aging.101625. View

10.

Chen S, Lin F, Zhu J, Ke Z, Lin T, Lin Y . An immune-related lncRNA prognostic model in papillary renal cell carcinoma: A lncRNA expression analysis. Genomics. 2020; 113(1 Pt 2):531-540. DOI: 10.1016/j.ygeno.2020.09.046. View

11.

Wang M, Mao C, Ouyang L, Liu Y, Lai W, Liu N . Correction to: Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 2019; 27(4):1447. PMC: 7206126. DOI: 10.1038/s41418-019-0394-6. View

12.

Wang C, Shi M, Ji J, Cai Q, Zhao Q, Jiang J . Stearoyl-CoA desaturase 1 (SCD1) facilitates the growth and anti-ferroptosis of gastric cancer cells and predicts poor prognosis of gastric cancer. Aging (Albany NY). 2020; 12(15):15374-15391. PMC: 7467382. DOI: 10.18632/aging.103598. View

13.

Shin D, Kim E, Lee J, Roh J . Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer. Free Radic Biol Med. 2018; 129:454-462. DOI: 10.1016/j.freeradbiomed.2018.10.426. View

14.

Torres-Bayona S, Aldaz P, Auzmendi-Iriarte J, Saenz-Antonanzas A, Garcia I, Arrazola M . PR-LncRNA signature regulates glioma cell activity through expression of SOX factors. Sci Rep. 2018; 8(1):12746. PMC: 6109087. DOI: 10.1038/s41598-018-30836-5. View

15.

Carbone M, Melino G . Stearoyl CoA Desaturase Regulates Ferroptosis in Ovarian Cancer Offering New Therapeutic Perspectives. Cancer Res. 2019; 79(20):5149-5150. DOI: 10.1158/0008-5472.CAN-19-2453. View

16.

Hao S, Yu J, He W, Huang Q, Zhao Y, Liang B . Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells. Neoplasia. 2017; 19(12):1022-1032. PMC: 5686465. DOI: 10.1016/j.neo.2017.10.005. View

17.

Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D . CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020; 19(1):43. PMC: 7045485. DOI: 10.1186/s12943-020-01168-8. View

18.

Lu J, Xu F, Lu H . LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53. Life Sci. 2020; 260:118305. DOI: 10.1016/j.lfs.2020.118305. View

19.

Nie J, Lin B, Zhou M, Wu L, Zheng T . Role of ferroptosis in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2018; 144(12):2329-2337. DOI: 10.1007/s00432-018-2740-3. View

20.

Zhang G, Fan E, Zhong Q, Feng G, Shuai Y, Wu M . Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer. Hum Genomics. 2019; 13(1):36. PMC: 6694645. DOI: 10.1186/s40246-019-0230-6. View